A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor
Abroad (travel likely)Recruiting
Conditions
Treatment · Neoantigen · Vaccine · Solid Tumor Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Study leads
Xianghua Wu, M.D
Principal Investigator
Fudan University
Qinghai Ji, M.D
Principal Investigator
Fudan University
Dongmei Ji, M.D
Principal Investigator
Fudan University